← All stocks

Labcorp

LH Scheduled selling only
CIK 0000920148 #284 in the set updated 17 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$954.06K
$954.06K on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 1 sales
Net
−$954.06K
$0.00 against sales at will

By person

24 insiders · 1 transaction
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
ANDERSON KERRII B
Director
$954.06K (1) scheduled
−$954.06K
6,563
0.0081%
$2.09M
−64.0%
Schechter Adam H
President & CEO
102,565
0.1265%
$32.62M
+9.5%
EISENBERG GLENN A
Executive Vice President
37,920
0.0468%
$12.06M
+21.2%
Caveney Brian J
EVP, Pres of BLS, CMO & CSO
36,492
0.0450%
$11.61M
+29.4%
BERBERIAN LANCE
EVP, Special Advisor, Strategy
18,652
0.0230%
$5.93M
+17.2%
NEUPERT PETER M
Director
13,784
0.0170%
$4.38M
+15.4%
Kong Garheng
Director
13,739
0.0169%
$4.37M
+15.5%
Schroeder Mark S
EVP, Pres Diagnostics & COO
12,677
0.0156%
$4.03M
+151.7%
Summy Amy B.
EVP, Chief Marketing Officer
6,956
0.0086%
$2.21M
+75.0%
Vaughn Bryan T
EVP and President, Diagnostics
6,746
0.0083%
$2.15M
+31.1%
Gilliland Dwight Gary
Director
6,656
0.0082%
$2.12M
−23.6%
van der Vaart Sandra D
EVP, Corporate Affairs
6,239
0.0077%
$1.98M
+65.8%
Davis Jeffrey A.
Director
5,460
0.0067%
$1.74M
+50.9%
GRAHAM ANITA Z
EVP, CHRO
5,185
0.0064%
$1.65M
+1,676%
Oyegunwa Akinbolade
EVP, CIO & CTO
5,064
0.0062%
$1.61M
+89.9%
Bailey Megan D.
EVP, Pres, Central Labs & Intl
4,851
0.0060%
$1.54M
+1,013%
Wengel Kathryn E
Director
4,133
0.0051%
$1.31M
+80.3%
Kyle Kathryn W
EVP, Chief Legal Officer
3,904
0.0048%
$1.24M
+27.9%
Meltzer Jonathan C
EVP, COO
3,620
0.0045%
$1.15M
+43.8%
Parham Richelle P
Director
3,366
0.0042%
$1.07M
−60.6%
Kliphouse Kirsten Marie
Director
3,160
0.0039%
$1.00M
+139.6%
Rothman Paul
Director
2,571
0.0032%
$817.63K
+252.2%
Wang Julia Aijun
Chief Financial Officer, EVP
1,817
0.0022%
$577.92K
+29,027%
Wilkinson Peter J
SVP, Chief Accounting Officer
1,770
0.0022%
$562.97K
+2.0%
Insider
Date
Role
Action
Shares
Price
Amount
ANDERSON KERRII B
17 Aug 2026
Director
Sold on a plan
3,000
$318.02
$954.06K

What was left out

Form 4 filings counted 5
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 1
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 0
History held since 7 Sep 2016